Immune booster shows promise against deadly yeast infections
NCT ID NCT04979052
First seen May 13, 2026 · Last updated May 13, 2026
Summary
This study tests whether adding an immune-boosting drug called interferon-gamma 1b to standard antifungal treatment can help clear Candida bloodstream infections faster. About 200 adults with a confirmed Candida infection in their blood will receive either standard therapy alone or standard therapy plus the study drug. The main goal is to see how quickly the infection clears from the blood and whether the combination is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire Vaudois
Lausanne, 1005, Switzerland
-
Duke University
Durham, North Carolina, 27708, United States
-
Hellenic Institute for the Study of Sepsis (HISS)
Athens, 11528, Greece
-
Klinikum Der Johann Wolfgang Von Goethe Universitaet
Frankfurt am Main, 60590, Germany
-
Radboudumc
Nijmegen, Gelderland, 6525 GA, Netherlands
-
Universitatea de Medicina si Farmacie luliu Hatieganu
Cluj-Napoca, 400348, Romania
Conditions
Explore the condition pages connected to this study.